Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METFORMIN\SAXAGLIPTIN: 1,093 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,093
Total FAERS Reports
117 (10.7%)
Deaths Reported
336
Hospitalizations
1,093
As Primary/Secondary Suspect
29
Life-Threatening
27
Disabilities

Active Ingredient: METFORMIN HYDROCHLORIDE\SAXAGLIPTIN HYDROCHLORIDE ·

First Report: 1980 · Latest Report: 20250618

What Are the Most Common METFORMIN\SAXAGLIPTIN Side Effects?

#1 Most Reported
Cardiac failure congestive
296 reports (27.1%)
#2 Most Reported
Cardiac failure
256 reports (23.4%)
#3 Most Reported
Cardiovascular disorder
154 reports (14.1%)

All METFORMIN\SAXAGLIPTIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Cardiac failure congestive 296 27.1% 48 117
Cardiac failure 256 23.4% 38 98
Cardiovascular disorder 154 14.1% 10 52
Blood glucose increased 84 7.7% 1 11
Diarrhoea 62 5.7% 5 7
Death 53 4.9% 53 4
Off label use 43 3.9% 2 10
Nausea 42 3.8% 0 12
Coronary artery disease 41 3.8% 8 24
Myocardial infarction 41 3.8% 2 32
Vomiting 40 3.7% 0 12
Drug dose omission 39 3.6% 0 2
Acute left ventricular failure 38 3.5% 3 31
Drug ineffective 37 3.4% 0 5
Pancreatitis 33 3.0% 2 18
Glycosylated haemoglobin increased 31 2.8% 0 5
Intentional product misuse 30 2.7% 0 4
Hyperglycaemia 29 2.7% 0 10
Lactic acidosis 29 2.7% 13 18
Medication residue present 28 2.6% 0 1

Who Reports METFORMIN\SAXAGLIPTIN Side Effects? Age & Gender Data

Gender: 50.0% female, 50.0% male. Average age: 61.4 years. Most reports from: US. View detailed demographics →

Is METFORMIN\SAXAGLIPTIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2002 1 0 1
2005 1 0 0
2007 2 0 1
2008 4 1 2
2009 2 0 1
2010 8 0 3
2011 14 0 8
2012 29 3 18
2013 32 6 21
2014 121 8 45
2015 114 8 59
2016 76 5 38
2017 61 5 28
2018 32 3 13
2019 17 6 1
2020 7 2 2
2021 20 5 4
2022 11 0 4
2023 12 2 3
2024 30 3 23
2025 6 0 3

View full timeline →

What Is METFORMIN\SAXAGLIPTIN Used For?

IndicationReports
Type 2 diabetes mellitus 467
Diabetes mellitus 194
Product used for unknown indication 47
Blood glucose abnormal 9
Blood glucose increased 6
Glucose tolerance impaired 5

METFORMIN\SAXAGLIPTIN vs Alternatives: Which Is Safer?

METFORMIN\SAXAGLIPTIN vs METFORMIN\SITAGLIPTIN METFORMIN\SAXAGLIPTIN vs METFORMIN\VILDAGLIPTIN METFORMIN\SAXAGLIPTIN vs METHADONE METFORMIN\SAXAGLIPTIN vs METHAMPHETAMINE METFORMIN\SAXAGLIPTIN vs METHENAMINE HIPPURATE METFORMIN\SAXAGLIPTIN vs METHIMAZOLE METFORMIN\SAXAGLIPTIN vs METHOCARBAMOL METFORMIN\SAXAGLIPTIN vs METHOHEXITAL METFORMIN\SAXAGLIPTIN vs METHOTREXATE METFORMIN\SAXAGLIPTIN vs METHOXSALEN

Official FDA Label for METFORMIN\SAXAGLIPTIN

Official prescribing information from the FDA-approved drug label.